Navigation Links
Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients
Date:6/3/2011

ication in therapeutic clinical trials," he concluded.

About OncoDefender-CRC

The OncoDefender-CRC assay, which is the only molecular prognostic test capable of accurately predicting risk of recurrence of cancer in patients previously treated with surgical resection of a Stage I/II colon cancer tumor or Stage I rectal cancer tumor, is commercially available in the United States.  The final 5-gene prognostic test was generated through genetic programming analysis of 422 CRC- and stroma-related genes. The test is performed at Everist Genomics' Ann Arbor-based clinical laboratory, which has been certified through the most stringent requirements (High Complexity) of the United States Clinical Laboratory Improvement Acts.  

As part of the company's commitment to make the test available to all patients regardless of insurance coverage or financial status, Everist Genomics offers a generous financial assistance program that can cover up to 80 percent of the cost of the OncoDefender-CRC test.

The test is performed on formalin-fixed paraffin-embedded cancer tissue taken at the time of surgery, and test results are issued within 7 to 10 days of receipt of tissues. The test does not report indeterminate or "no-call" results from any samples that meet quality acceptance and processing criteria.

About Colorectal Cancer

Colorectal cancer is one of the major causes of cancer death worldwide, accounting for more than 150,000 new cases and 55,000 deaths in the United States every year and 125,000 deaths each year in Europe.(1)  To date, surgery, followed by adjuvant chemotherapy when appropriate, is the mainstay of therapy for patients with localized disease. Of the estimated 68,000 patients that will be diagnosed with early stage colorectal cancer this year in the US, approximately 15% of stage I patients and 30% of stage II patients will recur following curative surgery. Many of these latter patients may have
'/>"/>

SOURCE Everist Genomics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Everist Genomics Announces Worldwide Availability of OncoDefender™-CRC
2. Genetics Squared Changes Name To Everist Genomics
3. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
4. CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study
5. Rosetta Genomics Announces Issuance of Additional U.S. Patent
6. WaferGen Appoints World-Renowned Clinical Genomics Cancer Researcher Dr. Arul M. Chinnaiyan to Scientific Advisory Board
7. NeoGenomics Awarded $374,000 in R&D Grants from the US Government
8. NeoGenomics Schedules its Q3 2010 Earnings Release for October 28, 2010
9. BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure
10. Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine
11. CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... NEW YORK , Aug. 28, 2014 ... has been commenced in the United States District Court ... on behalf of investors who purchased Galectin Therapeutics Inc. ... 6, 2014 and July 28, 2014. For ... The complaint alleges that during the Class Period the ...
(Date:8/28/2014)...   Edison Nation Medical , the premier ... for product ideas to improve the health and ... through the 6-month search ( www.EdisonNationMedical.com/Seniors ) will ... healthcare retailers with whom Edison Nation Medical has ... 65 and older. The objective of ...
(Date:8/28/2014)...  Seres Health, a clinical-stage therapeutics company developing ... microbiome, announced today that Dr. David Cook ... Chief Scientific Officer, will be presenting at the ... (ICAAC). The presentation will highlight the scientific and ... bacterial spores derived from the human microbiome, and ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3Seres Health to Present Clinical Findings at ICAAC 2014 Conference 2
... CRAIGAVON, Northern Ireland , August 2, 2010 ... a range of solutions,specifically designed to meet the needs of the ... , ... biopharma companies in adopting,biomarker strategies to enable them to better understand ...
... Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today that ... Healthcare Conference on Thursday, August 5, 2010 at 1:15 ... held at the Sheraton New York Hotel & Towers.  Steve Worland, Ph.D., ... Anadys and its clinical development programs. , ...
Cached Medicine Technology:Almac Launch Biomarkers for Biopharma 2Almac Launch Biomarkers for Biopharma 3Anadys Pharmaceuticals to Present at the BMO Capital Markets Healthcare Conference 2
(Date:8/28/2014)... Governor of Yucatán, Rolando Zapata Bello, presented the ... event is organized by the Microcredit Summit Campaign in ... Microenterprise Financing Program ( PRONAFIM ) and will take ... Convention Center Yucatan Siglo XXI in the city of ... to host the 17th Microcredit Summit logistically but especially ...
(Date:8/28/2014)... August 28, 2014 Bank lending to the ... year, down by 0.13% in real terms, and continuing to ... new study by UHY, the international accountancy network. , UHY ... businesses in particular, the credit crunch lingers on. , UHY ... the last year have been wiped out by inflation. Over ...
(Date:8/28/2014)... fall from trees and learn to flap their forelimbs to ... pump their "arms" to get aloft? , The answer is ... University of California, Berkeley, study provides a new piece of ... midair, a talent that could have helped their ancestors learn ... study looked at how baby birds, in this case chukar ...
(Date:8/28/2014)... Albert Einstein College of Medicine of Yeshiva University ... Sudan ebolavirus (SUDV), one of the two most lethal strains ... now devastating West Africa. First identified in 1976, SUDV has ... that have killed more than 400 people in total. The ... , Between 30 and 90 percent of people infected with ...
(Date:8/28/2014)... herbal medication practitioner in Melbourne for back pain ... of intensive care and emergency physicians to call ... complementary medications. , Writing in Emergency Medicine ... for Emergency Medicine, emergency medicine trainees Dr Angelly ... Care Unit at the Royal Melbourne Hospital and ...
Breaking Medicine News(10 mins):Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 3Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 2Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 3Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 4Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 5Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 6Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 7Health News:Flapping baby birds give clues to origin of flight 2Health News:Flapping baby birds give clues to origin of flight 3Health News:Drug shows promise against Sudan strain of Ebola in mice 2Health News:Deadly remedy: Warning issued about Chinese herbal medicine 2
... Annual JMP Securities Research Conference ... on May 21 - ... Meeting on May 22 -, SAN DIEGO, May 14 Ardea Biosciences, Inc.,(Nasdaq: ... Annual Research Conference. Additionally, Ardea will be,hosting a live webcast and conference call of ...
... 14 Biotel Inc. (OTC Bulletin,Board: BTEL) announced results ... earnings of $99,000, or $0.03 per diluted share, on ... or $0.07 per diluted,share, on revenues of $2,990,000 for ... ended March 31, 2008, Biotel had net earnings of ...
... Patients more likely to survive using chemoradiation, and new ... -- Tonsil and tongue cancers linked to human papillomavirus ... treatments, while those that express high levels of a ... most deadly, a new study concludes. , University of ...
... other treatments work well, too, giving patients options , , WEDNESDAY, ... kind supports the use of a popular three-drug regimen for ... drugs is a good alternative. , But an older ... Sharon Riddler, assistant professor of medicine at the University of ...
... , , WEDNESDAY, May 14 (HealthDay News) -- A bundle of ... cardiovascular disease in a study of older Swedish men, researchers ... long process that might one day lead to widespread medical ... such as high blood pressure and cholesterol, said Dr. Johan ...
... Honored for Their Research -, PALO ALTO, ... Ph.D. students and two professors with the company,s ... field of organic,chemistry. The winners participated in Roche,s ... on the important role of organic,chemistry in pharmaceutical ...
Cached Medicine News:Health News:Ardea Biosciences Announces Upcoming Corporate Meetings 2Health News:Ardea Biosciences Announces Upcoming Corporate Meetings 3Health News:Biotel Announces Profitable Third Quarter Ended March 31, 2008 2Health News:HPV Tied to Better Tongue, Tonsil Cancer Outcomes 2Health News:Study Supports Popular HIV Drug Regimen 2Health News:Study Supports Popular HIV Drug Regimen 3Health News:Biomarkers Predict Heart Deaths 2Health News:Biomarkers Predict Heart Deaths 3Health News:Roche Symposium Showcases Accomplishments of Next Generation of Chemists 2Health News:Roche Symposium Showcases Accomplishments of Next Generation of Chemists 3
... is a revolutionary Electronic Medical Office (EMO) ... and customized for the unique needs of ... benefits of an electronic record system (EMR, ... entire practice to a new level of ...
... prescription writing, referral letters, chart pulls, transcription, ... ,able to add more appointments to the ... on the exam documentation created by the ... appropriate E&M ,code for the visit - ...
... Electronic Medical Office (EMO) for the Optometry ... your practice. In addition to retrieving and ... integrates the patient office flow including documentation ... billing information. ChartLogic also gives you data ...
... AcerMed's Cardiology specific EMR / PM ... Cardiologists nationwide,enabling more effective patient care ... staff clinicians with critical information on ... patient care.,Our Cardiology specific clinical pathways ...
Medicine Products: